Gene · 10049
Papers2,435
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,435
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential MicroRNA Expression in Porcine Endometrium Related to Spontaneous Embryo Loss during Early Pregnancy. | Int J Mol Sci | 2022 | 35897733 | PubTator, text mining | PubMed |
| Frequency of Parkinson's Disease Genes and Role of PARK2 in Amyotrophic Lateral Sclerosis: An NGS Study. | Genes (Basel) | 2022 | 35893043 | PubTator, text mining | PubMed |
| Advances in Crosstalk between Porcine Circoviruses and Host. | Viruses | 2022 | 35891399 | PubTator, text mining | PubMed |
| Identification of Exported Plasmodium falciparum Proteins That Bind to the Erythrocyte Cytoskeleton. | Microorganisms | 2022 | 35889157 | PubTator, text mining | PubMed |
| The Chaperone System in Breast Cancer: Roles and Therapeutic Prospects of the Molecular Chaperones Hsp27, Hsp60, Hsp70, and Hsp90. | Int J Mol Sci | 2022 | 35887137 | PubTator, text mining | PubMed |
| MicroRNAs in Dystrophinopathy. | Int J Mol Sci | 2022 | 35887128 | PubTator, text mining | PubMed |
| Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code. | Cancers (Basel) | 2022 | 35884464 | PubTator, text mining | PubMed |
| Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets. | Cell Death Discov | 2022 | 35879279 | PubTator, text mining | PubMed |
| Amyloid Fibril Formation of Arctic Amyloid-β 1-42 Peptide is Efficiently Inhibited by the BRICHOS Domain. | ACS Chem Biol | 2022 | 35876740 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of Exercise-Related Biomarkers in Diabetes. | Genet Res (Camb) | 2022 | 35855056 | PubTator, text mining | PubMed |
RSPO1-mutated keratinocytes from palmoplantar keratoderma display impaired differentiation, alteration of cell-cell adhesion, EMT-like phenotype and invasiveness properties: implications for squamous cell carcinoma susceptibility in patients with 46XX disorder of sexual development. | Orphanet J Rare Dis | 2022 | 35854363 | PubTator, text mining | PubMed |
| Putting human Tid-1 in context: an insight into its role in the cell and in different disease states. | Cell Commun Signal | 2022 | 35854300 | PubTator, text mining | PubMed |
| SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk. | Cancer Discov | 2022 | 35819319 | PubTator, text mining | PubMed |
| A Novel Ferroptosis-Related Gene Signature to Predict Prognosis of Esophageal Carcinoma. | J Oncol | 2022 | 35813863 | PubTator, text mining | PubMed |
| Case Report: A Novel Splice-Site Mutation in DNAJB6 Associated With Juvenile-Onset Proximal-Distal Myopathy in a Chinese Patient. | Front Genet | 2022 | 35812750 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing. | Clin Transl Med | 2022 | 35808806 | PubTator, text mining | PubMed |
| Functional Bacterial Amyloids: Understanding Fibrillation, Regulating Biofilm Fibril Formation and Organizing Surface Assemblies. | Molecules | 2022 | 35807329 | PubTator, text mining | PubMed |
| Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment. | Int J Mol Sci | 2022 | 35805884 | PubTator, text mining | PubMed |
| Tissue-Based Proteomic Profiling in Patients with Hyperplasia and Endometrial Cancer. | Cells | 2022 | 35805203 | PubTator, text mining | PubMed |
| The Role of Heat Shock Protein 70 Subfamily in the Hyperplastic Prostate: From Molecular Mechanisms to Therapeutic Opportunities. | Cells | 2022 | 35805135 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10049/papers?page=21